Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Malfitano AM1"'
Publikováno v:
Recent patents on CNS drug discovery (2016).
info:cnr-pdr/source/autori:Bifulco M, Laezza C, Malfitano AM1./titolo:Endocannabionoid System in Neurological Disorders./doi:/rivista:Recent patents on CNS drug discovery/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Bifulco M, Laezza C, Malfitano AM1./titolo:Endocannabionoid System in Neurological Disorders./doi:/rivista:Recent patents on CNS drug discovery/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume
BACKGROUND: Several studies support the evidence that the endocannabinoid system and cannabimimetic drugs might have therapeutic potential in numerous pathologies. These pathologies range from neurological disorders, atherosclerosis, stroke, cancer t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::d516e5c52e2af4cf09fbbf7c3739e61c
http://www.cnr.it/prodotto/i/357533
http://www.cnr.it/prodotto/i/357533
Autor:
Ciaglia E1, 2, Torelli G3, 4, Pisanti S1, Picardi P1, D'Alessandro A2, Laezza C5, 6, Malfitano AM1, Fiore D2, Pagano Zottola AC2, Proto MC2, Catapano G3, Gazzerro P2, Bifulco M1
Publikováno v:
Oncotarget (2015).
info:cnr-pdr/source/autori:Ciaglia E1,2, Torelli G3,4, Pisanti S1,2, Picardi P1,2, D'Alessandro A2, Laezza C5,6, Malfitano AM1,2, Fiore D2, Pagano Zottola AC2, Proto MC2, Catapano G3, Gazzerro P2, Bifulco M1,2./titolo:Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells./doi:/rivista:Oncotarget/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
info:cnr-pdr/source/autori:Ciaglia E1,2, Torelli G3,4, Pisanti S1,2, Picardi P1,2, D'Alessandro A2, Laezza C5,6, Malfitano AM1,2, Fiore D2, Pagano Zottola AC2, Proto MC2, Catapano G3, Gazzerro P2, Bifulco M1,2./titolo:Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells./doi:/rivista:Oncotarget/anno:2015/pagina_da:/pagina_a:/intervallo_pagine:/volume
Herein we show that a majority of human brain tumor samples and cell lines over-expressed cannabinoid receptor CB1 as compared to normal human astrocytes (NHA), while uniformly expressed low levels of CB2. This finding prompted us to investigate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::bd26161855b01bdfb903c4fc956bd5f3
https://publications.cnr.it/doc/331491
https://publications.cnr.it/doc/331491